C1 esterase inhibitor recombinant Intravenous and Lithium Capsules
Determining the interaction of C1 esterase inhibitor recombinant Intravenous and Lithium Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1 esterase inhibitor recombinant Intravenous-Lithium Capsules and Tablets
- C1 esterase inhibitor recombinant Intravenous-Lithium Carbonate
- C1 esterase inhibitor recombinant Intravenous-Lithium Carbonate ER Tablets
- C1 esterase inhibitor recombinant Intravenous-Lithium Carbonate Tablets
- C1 esterase inhibitor recombinant Intravenous-Lithium Citrate Syrup
- C1 esterase inhibitor recombinant Intravenous-Lithium Controlled-Release and Extended-Release Tablets
- Lithium Capsules-C1 esterase inhibitor, human Intravenous
- Lithium Capsules-C1 Inhibitor (Human)
- Lithium Capsules-C1 Inhibitor (Human) (Berinert)
- Lithium Capsules-C1 Inhibitor (Human) (Cinryze)
- Lithium Capsules-C1 Inhibitor (Human) (Haegarda)
- Lithium Capsules-C1 Inhibitor (Recombinant)